GERON
Geron designs, manufactures, and sells textile carding equipments.
GERON
Industry:
Machinery Manufacturing Manufacturing Textiles
Founded:
1987-01-01
Status:
Active
Contact:
86513-8517 8888
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Font Awesome Apache Mobile Non Scaleable Content Nginx PHP Apache 2.4
Similar Organizations
Norwalk Compressor
Norwalk Compressor designs, manufactures and services compression equipment.
Toread Holdings Group
Toread Holdings Group designs, manufactures, and retails camping and outdoor equipment.
Stock Details
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-03-17 | Webuy | Geron investment in Series A - Webuy | 3 M CNY |
| 2016-08-28 | UnionCotton | Geron investment in Seed Round - UnionCotton | N/A |
| 2016-07-18 | Isoubu | Geron investment in Series A - Isoubu | 50 M CNY |
More informations about "Geron"
Geron Corporation - Investors & Media
Mar 11, 2025 Geron is a commercial-stage biopharmaceutical company with a first-in-class telomerase inhibitor that is approved in the United States for the treatment of certain adult …See details»
Our tireless pursuit | Geron
With a seasoned leadership team with world-class expertise spanning research, clinical development, regulatory, manufacturing and commercial experience in hematologic …See details»
Geron Corporation - Wikipedia
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. See details»
Geron Corporation (GERN) - Yahoo Finance
Find the latest Geron Corporation (GERN) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Our leadership team | Geron
Our leadership With a seasoned leadership team with world-class expertise spanning research, clinical development, regulatory, manufacturing and commercial experience in hematologic malignancies, Geron is prepared to …See details»
Geron Corporation Announces Departure of Chief Executive Officer
Mar 11, 2025 Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced …See details»
Geron
Scientific study of aging: The Gerontological Society of America (GSA) is a leading, forward-thinking interdisciplinary organization devoted to research, education, advocacy and practice in all …See details»
Geron Corporation - Geron Corporation Announces Up to $375 …
Nov 7, 2024 Geron received $250 million in gross proceeds at closing, with access to an additional $125 million in debt Strengthens balance sheet to support the commercial launch of …See details»
Geron to Participate at Upcoming Investor Conferences in March …
Feb 21, 2025 FOSTER CITY, Calif., February 21, 2025--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that members of the …See details»
Geron Corporation Reports Fourth Quarter and Full Year 2024 …
Feb 26, 2025 FOSTER CITY, Calif., February 26, 2025--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course …See details»
Our story continues to evolve | Geron
Geron Corporation – Geron Announces European Commission Approval of RYTELO® (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adults with Transfusion …See details»
Geron Corporation Announces Departure of Chief Executive Officer
Mar 11, 2025 Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today anSee details»
Levi & Korsinsky Reminds Geron Corporation Investors of the …
9 hours ago NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Geron Corporation ("Geron" or the "Company") NASDAQ:GERN of a class …See details»
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Geron …
9 hours ago ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Geron Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – GERNSee details»
Advancing how blood cancers are treated | Geron
Geron is exploring the broad potential of telomerase inhibition across multiple myeloid hematologic malignancies.See details»
Geron Corporation Announces Up to $375 Million in Funding with …
Nov 7, 2024 FOSTER CITY, Calif., November 07, 2024--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course …See details»
Geron Corp.: How Concerned Should We Be About Rytelo Sales?
Mar 17, 2025 Geron Corp's imetelstat, branded as Rytelo, launched in 2024 for lower risk MDS, with promising expansion into myelofibrosis and other indications. Despite initial market …See details»
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Geron
9 hours ago WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Geron Corporation (NASDAQ: GERN) between February 28, 2024 and February …See details»
GERN Investors Have Opportunity to Lead the Geron Corporation ...
Mar 17, 2025 Geron also failed to inform investors that Rytelo lacked necessary patient awareness for the Company to capitalize on what it had claimed was a significant unmet need …See details»
Our culture sets us apart | Geron
At Geron, our innovative and collaborative culture has been foundational to advancing our mission to change lives by changing the course of blood cancer. Our vision can only be accomplished …See details»